MedPath

A clinical trial to compare the evaluation of efficacy, safety and tolerability of three expectorants in the treatment of productive cough associated with acute bronchitis, AECB, pneumonia and asthmatic bronchitis in Indian populatio

Phase 4
Completed
Registration Number
CTRI/2009/091/000112
Lead Sponsor
Glenmark Pharmaceuticals LtdBD Sawant Marg, Chakala, Off. Western Express Highway, Andheri (E), Mumbai 400 099
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
354
Inclusion Criteria

1.Patients of either sex 18-65 years
2.Subjects giving written informed consent
3.Patients with Productive Cough associated with Acute Bronchitis, AECB, Pneumonia and Asthmatic Bronchitis
4.In the opinion of the investigator, able to comply with the requirements of the protocol.

Exclusion Criteria

1.Patients with Cystic Fibrosis
2.Patients with Active Tuberculosis
3.Patients with lung cancer or lung metastasis
4.Patients with severe bronchiectasis
5.Patients with acute respiratory decompensation
6.Patients with Chronic respiratory insufficiency associated with resting hypoxemia,
7.Patients requiring hospitalization for parenteral antibiotic treatment
8.Patients with hypersensitivity against the medication under study
9.Patients with Female patients with child bearing potential-
Who are pregnant
Who are breastfeeding
Who are not practicing acceptable methods of birth control

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the change in consistency of sputum between the test and reference drugsTimepoint: End of study
Secondary Outcome Measures
NameTimeMethod
To compare the change in volume of sputum, frequency and severity of cough, breathlessness from baseline and between the groups.Timepoint: End of study
© Copyright 2025. All Rights Reserved by MedPath